fundvisualizer.com

NYLI WMC Value Class AMAPAX

Performance (before sales charge)

As of 08/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 07/31/2024
Stock
92.68%
Non-U.S. Stock
6.21%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.09%
Other
0.01%

Due to rounding, percentages may not equal 100%.

Sectors

As of 07/31/2024

Basic materials

1.12%

Consumer cyclical

7.01%

Financial services

21.39%

Real estate

5.07%

Consumer defensive

6.84%

Health care

19.71%

Utilities

3.01%

Communication services

3.79%

Energy

8.31%

Industrials

12.51%

Technology

10.13%

Top 10 holdings

As of 07/31/2024

JPMorgan Chase & Co
3.92%
UnitedHealth Group Inc
3.86%
Johnson & Johnson
2.88%
Pfizer Inc
2.30%
Cisco Systems Inc
2.30%
Elevance Health Inc
2.07%
MetLife Inc
1.86%
American International Group Inc
1.79%
M&T Bank Corp
1.77%
Johnson Controls International PLC
1.70%
Fund assets

$1.01 Billion

Share class

A

Morningstar category

Large Value

Expense ratio

1.04%

Investment objective

Growth

Documents